骨关节炎治疗市场：按药物、治疗方法和地区划分

预计到 2026 年，骨关节炎治疗市场规模将达到 67.8 亿美元，到 2033 年将达到 129.4 亿美元，2026 年至 2033 年的年复合成长率（CAGR）为 9.2%。

由于骨关节炎（一种主要影响膝关节、髋关节和手部的退化性关节疾病）患者数量不断增加，骨关节炎治疗市场正在扩张。人口老化、生活方式改变和肥胖率上升是导致该疾病在全球范围内发病率不断上升的主要原因。该市场提供多种治疗方案，包括药物治疗（如非类固醇消炎剂(NSAIDs)、皮质类固醇和缓解疾病药物）以及非药物治疗（如物理治疗、生活方式调整和手术干预）。医疗技术的创新和微创手术的进步正在拓展治疗选择，改善患者预后，并促进骨关节炎的有效管理。

人们日益重视早期诊断和积极治疗，这推动了先进治疗方案的普及。製药公司、医疗设备製造商和医疗服务提供者正在开发标靶治疗和个人化护理方案，以满足每位患者的个别需求。持续的研发投入，加上医疗服务覆盖范围的扩大，正在为以患者为中心的高效骨关节炎管理创造一个充满活力的市场。

市场动态

骨关节炎治疗市场的主要驱动力是全球骨关节炎盛行率的不断上升，而盛行率的上升又受到人口老化、久坐不动的生活方式以及肥胖率上升的影响。随着全球人口老化，对有效缓解关节疼痛和活动障碍的解决方案的需求持续增长。患者越来越倾向于寻求药物和非药物干预措施来缓解症状、延缓疾病进展并维持积极的生活方式。人们对早期诊断和积极治疗重要性的认识不断提高，以及在出现症状初期就寻求医疗协助的意愿增强，也促进了市场成长。

技术进步和治疗方法的创新正在进一步重塑市场格局。微创手术、标靶药物输送系统和再生医学因其能够改善患者预后并缩短康復时间而备受关注。製药公司正大力投资研发针对骨关节炎特定机制的新药和生物製药製剂，而医疗设备製造商则不断推出先进的植入和关节重建解决方案。这些创新正在改善治疗效果，并为以往治疗选择有限的患者拓展治疗选择。

儘管有这些机会，市场仍面临许多挑战，例如治疗成本不断上涨、新兴地区认知度有限以及长期药物治疗可能产生的副作用。此外，针对每位患者的具体病情制定个人化治疗方案的需求，也需要持续进行研究和临床试验。然而，疾病盛行率的上升、患者认知度的提高以及治疗方法的不断进步，共同创造了一个充满活力的市场环境，致力于改善骨关节炎患者的生活品质。

本次调查的主要特点

• 本报告对骨关节炎治疗市场进行了详细分析，以 2025 年为基准年，给出了预测期（2026-2033 年）的市场规模（十亿美元）和復合年增长率（%）。
• 该报告还重点介绍了各个细分市场的潜在商机，并概述了该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
• 该研究根据以下参数对骨关节炎治疗市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告的研究结果将有助于负责人和经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 这份骨关节炎治疗市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过骨关节炎治疗市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场范围

• 报告概述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、监理及趋势分析

• 市场动态
  • 司机
  • 抑制因素
  • PEST分析
  • 波特五力分析
  • 市场机会
  • 法规环境
  • 重大进展
  • 产业趋势

4. 2026-2033年全球骨关节炎治疗药物市场概况

• 乙酰胺酚
• 非类固醇消炎剂

5. 2026-2033年全球骨关节炎治疗市场（依治疗方法）

• 非药物疗法
• 药物治疗
• 手术治疗

6. 2026-2033年全球骨关节炎治疗市场（依最终使用者划分）

• 医院
• 诊所
• 家

7. 2026-2033年全球骨关节炎治疗市场（按地区划分）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第八章 竞争情势

• 热图分析
• 市占率分析（3x3矩阵）
• 公司简介
  • Johnson &Johnson Ltd.
  • Abbott Laboratories
  • Pfizer, Inc.
  • Novartis AG
  • Eli Lily and Co.
  • Abiogen Pharma
  • Ampio Pharmaceuticals
  • Halyard Health
  • BioDelivery Sciences International, Inc.

第九章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十章各节

• 参考
• 调查方法

Osteoarthritis Treatment Market is estimated to be valued at USD 6.78 Bn in 2026 and is expected to reach USD 12.94 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2033.

The osteoarthritis treatment market is expanding as more people are diagnosed with osteoarthritis, a degenerative joint disease that mainly affects the knees, hips, and hands. Aging populations, lifestyle changes, and rising obesity rates are driving the increasing incidence of the condition worldwide. The market offers a variety of treatment options, including pharmacological therapies such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying agents, alongside non-pharmacological approaches like physical therapy, lifestyle modifications, and surgical interventions. Innovations in medical technology and minimally invasive procedures are enhancing treatment options, improving patient outcomes, and helping individuals manage osteoarthritis more effectively.

Growing awareness of early diagnosis and proactive care is encouraging the adoption of advanced treatment solutions. Pharmaceutical companies, medical device manufacturers, and healthcare providers are developing targeted therapies and personalized care plans to meet patient-specific needs. Ongoing research and wider healthcare access are creating a dynamic market focused on delivering effective, patient-centered osteoarthritis management.

Market Dynamics

The osteoarthritis treatment market is primarily driven by the increasing prevalence of osteoarthritis worldwide, fueled by aging populations, sedentary lifestyles, and rising obesity rates. As the global population grows older, the demand for effective management solutions for joint pain and mobility issues continues to rise. Patients are increasingly seeking both pharmacological and non-pharmacological interventions to relieve symptoms, delay disease progression, and maintain an active lifestyle. The growing awareness of the importance of early diagnosis and proactive care is also contributing to market growth, as individuals are more likely to seek medical attention at the onset of symptoms.

Technological advancements and innovations in treatment approaches are further shaping the market landscape. Minimally invasive surgical procedures, targeted drug delivery systems, and regenerative therapies are gaining traction due to their ability to improve patient outcomes while reducing recovery times. Pharmaceutical companies are investing heavily in the development of new drugs and biologics that target specific mechanisms of osteoarthritis, while medical device manufacturers are introducing advanced implants and joint replacement solutions. These innovations are enhancing the effectiveness of treatment and expanding options for patients who previously had limited choices.

Despite these opportunities, the market faces challenges such as high treatment costs, limited awareness in emerging regions, and potential side effects of long-term pharmacological therapies. Additionally, the need for personalized treatment plans to address patient-specific conditions requires continuous research and clinical trials. Nevertheless, the combination of rising disease prevalence, increasing patient awareness, and ongoing advancements in treatment modalities is creating a dynamic market environment focused on improving quality of life for individuals living with osteoarthritis.

Key Features of the Study

• This report provides in-depth analysis of the Osteoarthritis Treatment Market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Osteoarthritis Treatment Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Johnson & Johnson Ltd., Abbott Laboratories, Pfizer, Inc., Novartis AG, Eli Lily and Co., Abiogen Pharma, Ampio Pharmaceuticals, Halyard Health, and BioDelivery Sciences International, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Osteoarthritis Treatment Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Osteoarthritis Treatment Market

Market Segmentation

• By Medications
  • Acetaminophen
  • Non- Steroidal Anti- Inflammatory
• By Therapies
  • Non- Pharmacological Therapy
  • Pharmacological Therapy
  • Surgical Treatment
• By End-user
  • Hospitals
  • Clinics
  • Household
• By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Johnson & Johnson Ltd.
  • Abbott Laboratories
  • Pfizer, Inc.
  • Novartis AG
  • Eli Lily and Co.
  • Abiogen Pharma
  • Ampio Pharmaceuticals
  • Halyard Health
  • BioDelivery Sciences International, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Medications
  • Market Snippet, By Therapies
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • PEST Analysis
  • PORTER's Five Forces Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Osteoarthritis Treatment Market , By Medications, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Acetaminophen
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Non-Steroidal Anti- Inflammatory
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

5. Global Osteoarthritis Treatment Market , By Therapies, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Non-Pharmacological Therapy
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Pharmacological Therapy
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Surgical Treatment
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

6. Global Osteoarthritis Treatment Market , By End User, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Clinics
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Household
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

7. Global Osteoarthritis Treatment Market , By Region, 2026-2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Medications, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapies, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Medications, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapies, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Medications, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapies, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Medications, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapies, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Medications, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapies, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
  • Market Size and Forecast, By Medications, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Therapies, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
  • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
  • Johnson & Johnson Ltd.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Abbott Laboratories
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Pfizer, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Novartis AG
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Eli Lily and Co.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Abiogen Pharma
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Ampio Pharmaceuticals
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • Halyard Health
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates
  • BioDelivery Sciences International, Inc.
    • Company Overview
    • Product Type Portfolio
    • Recent Developments/Updates

9. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Section

• References
• Research Methodology
• About Us and Sales Contact